Research Insights Archive

Home » Research & Resources » Research Insights »Research Insights Archive

November 25, 2019 – Anticholinergic properties and cognition, relevancy to individuals with Parkinson’s Disease (PD)

Medications with anticholinergic activity are used in 8-37 % of older adults to treat various medical conditions that involve contraction and relaxation of muscles, such as PD and overactive bladder, as well as other conditions including seasonal aller …

September 24, 2019 – Impulse Control Disorders in Parkinson’s Disease: A 20-year Odyssey

Citation: Weintraub, D. (2019). Impulse control disorders in Parkinson’s disease: A 20‐year odyssey. Movement Disorders. Impulse Control Disorders (ICDs) are behavioral problems resulting from a person’s difficulty with or inability to resist the drive …

July 22, 2019 – Subthalamic Stimulation, Apomorphine, and Levodopa Infusion in Parkinson’s Disease

Citation: Dafsari, H. S., Martinez‐Martin, P., Rizos, A., Trost, M., dos Santos Ghilardi, M. G., Reddy, P., & Barbe, M. T. (2019). EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson’s disease. Movement Disorders, s3 …

May 22, 2019 – Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimize Quality of Life

Citation: Daneault, J., Vergara-Diaz, G. & Lee, S. I. (2016). Clinical Management of Drug-Induced Dyskinesia in Parkinson’s Disease: Why Current Approaches May Need to Be Changed to Optimise Quality of Life. European Medical Journal, 1, 62-69. Intr …

March 22, 2019 – Profile of Inhaled Levodopa and its Potential in the Treatment of Parkinson’s Disease: Evidence to Date

Citation: Patel, A. B., & Jimenez-Shahed, J. (2018). Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date. Neuropsychiatric disease and treatment, 14, 2955. Introduction: Levodopa has been the gold …

January 21, 2019 – Predictors to Quality of life improvements after subthalamic stimulation in Parkinson’s Disease

Citation: Liu, F. T., Lang, L. Q., Yang, Y. J., Zhao, J., Feng, R., Hu, J., … & Wu, J. J. (2018). Predictors to quality‐of‐life improvements after subthalamic stimulation in Parkinson’s disease. Acta Neurologica Scandinavica.  Introduction: Subth …

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2020 The Parkinson Alliance. All rights reserved.